SNY
Sanofi
Set alert
44.34 USD +1.21 +2.81%
44.23 Day range 45.29
39.12 52-week range 52.34
- YTD
- -8.50%
- 1 year
- -12.96%
- Open
- 44.82
- Prev close
- 43.13
- Mkt cap
- 106.24B
- Vol
- 15.10M
- Avg vol
- 2.87M
- EPS
- 1.90
- P/E
- 23.34
- Div yield
- 5.61%
More statistics
- Low
- 44.23
- High
- 45.29
- Forward P/E
- 8.49
- Beta
- 0.28
- Short ratio
- 3.47
- Inst. own
- 8.01%
- Dividend
- 2.42
- Ex-div date
- May 3, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 42.22
- 200-d avg
- 44.34
- 1y target
- 53.61
Financial health
Altman Z-Score
1.56 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 5
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E 12.9×
FY 2016 5y median 17.7× FY 2025
P/S 2.2×
FY 2016 5y median 2.7× FY 2025
P/B 1.4×
FY 2016 5y median 1.5× FY 2025
P/FCF 9.9×
FY 2016 5y median 13.4× FY 2025
EV/EBITDA 9.1×
FY 2016 5y median 10.6× FY 2025
EV/Sales 2.4×
FY 2016 5y median 3.0× FY 2025
FCF Yield 10.1%
FY 2016 5y median 7.4% FY 2025
Profitability
Gross Margin 72.1%
FY 2016 5y median 70.2% FY 2025
Operating Margin 20.5%
FY 2016 5y median 20.5% FY 2025
Net Margin 16.7%
FY 2016 5y median 15.9% FY 2025
ROE 10.9%
FY 2016 5y median 9.1% FY 2025
ROIC 7.7%
FY 2016 5y median 6.4% FY 2025
ROA 6.2%
FY 2016 5y median 5.2% FY 2025
Growth (YoY)
Revenue 5.5%
FY 2016 FY 2025
Operating Income 32.3%
FY 2016 FY 2025
EPS (diluted) 45.8%
FY 2016 FY 2025
Free Cash Flow 72.3%
FY 2016 FY 2025
Financial Health
Current Ratio 1.1×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 0.7×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 1.0×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 15.3×
FY 2016 5y median 15.3× FY 2025
Dividends
Dividend Yield 5.3%
FY 2016 5y median 3.9% FY 2025
Payout Ratio 68.9%
FY 2016 5y median 68.9% FY 2025
Annual · latest fiscal year ends 2025-12-31